Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial
[PTREC]
Effects of High-Intensity Interval and Moderate Intensity Continuous Exercise on Diabetic Obese Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial
1 other identifier
interventional
48
1 country
1
Brief Summary
background: Obesity, diabetes mellitus type II and fatty liver disease combining with low levels of physical activity are prominent health risks for mortality and morbidity. More than 1/3 of the current population is suffering from obesity with a significant proportion to medical complications which can negatively influence their quality of life. These complications comprise alterations of the metabolism of glucose and fat, insulin resistance and diabetes mellitus. Objectives The purpose of this study was to compare between high intensity interval exercise and moderate intensity continuous on diabetic obese patients with NAFLD. Methods: forty-seven diabetic obese individuals with NAFLD were enrolled in this study. The individuals were randomly divided into 16 in HII group, 15 in MIC group, and 16 in the controls. HII group received HII exercise, MIC group received 8-week MIC exercise while the control group did not receive any exercise intervention. IHTG and visceral lipids were assessed pre- and post-intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
December 12, 2018
CompletedFirst Posted
Study publicly available on registry
December 13, 2018
CompletedJune 26, 2020
June 1, 2020
1.1 years
December 12, 2018
June 24, 2020
Conditions
Outcome Measures
Primary Outcomes (8)
Intrahepatic triglyceride (%)
Assessment in percentage (%) using MRI with a 3T scanner (General electric, WI) through imaging of chemical shift. Each patient was assessed for imaging in the supine position using the body coil. The patient was instructed to make a single breath hold during imaging, the liver was imaged 3 separate images slice pairs. IHTG proportionate to water was estimated as 100 × (signal amplitude of TG)/(signal amplitude of water).
8 weeks
Total cholesterol
Total cholesterol, (mg/dL)
8 weeks
Triglycerides
Triglycerides, (mg/dL)
8 weeks
High-density lipoproteins (HDLs)
High-density lipoproteins (HDLs), (mg/dL)
8 weeks
Low-density lipoproteins (LDLs)
Low-density lipoproteins (LDLs), (mg/dL)
8 weeks
Alanine-transaminase (ALT)
Alanine-transaminase (ALT), (IU/L)
8 weeks
Hemoglobin A1c (HbA1c)
Hemoglobin A1c (HbA1c), (%)
8 weeks
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
It was assessed through Blood Code Calculation: HOMA-IR = Insulin (mU/L) х Glucose (mg/dL).
8 weeks
Secondary Outcomes (4)
Weight
8 weeks
Height
8 weeks
Body mass index (BMI)
8 weeks
Visceral adipose fat
8 weeks
Study Arms (3)
Study group 1
ACTIVE COMPARATORHigh Intensity Interval Excercise
Study group 2
ACTIVE COMPARATORModerate Intensity Interval Exercise
Control group
NO INTERVENTIONNo Intervention
Interventions
Different Interval intensities Exercise
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of NAFLD, type II DM, and obesity.
- Body mass index (BMI) ≥30 kg/m2.
- Age: 40-60 years
- No smoking.
You may not qualify if:
- Severe life limiting illness (cancer, renal failure),
- Uncontrolled heart disease,
- Neuromuscular limitations,
- Orthopedic problems
- Endocrine disorders that could affect physical exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahlia Universitylead
- Cairo Universitycollaborator
Study Sites (1)
Dr Sayed Tanatwy
Giza, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sayed A Tantawy, PhD
Cairo University, Giza, Egypt
- STUDY DIRECTOR
Walid K Abdelbasset, PhD
Cairo University, Giza, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- HII group, each patient in this group were conducted a program of high-intensity aerobic exercise for 8 weeks, three times per week with each exercise session lasting for nearly 40 minutes morning. Each patient was instructed to not eat for 2 hours before the exercise session to avoid exercise induced airway obstruction. MIC group, each patient was received (MIC 3 times/week) for eight weeks, according to following parameters; 5 minutes warm up, followed by 30 minutes of continuous aerobic exercise on a cycle Ergometer with constant intensity at 70 to 75% of peak HR and 5 minutes cool down. Also, these measures were obtained at the beginning and the end of the intervention. Control group only received medical treatment with no exercise intervention
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 12, 2018
First Posted
December 13, 2018
Study Start
July 9, 2017
Primary Completion
August 10, 2018
Study Completion
December 10, 2018
Last Updated
June 26, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share